This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Anderson, K. P. Articles by Urie, P. M. Search for Related Content PubMed PubMed Citation Articles by Anderson, K. P. Articles by Urie, P. M.

Circulation, Vol 79, 948-958, Copyright © 1989 by American Heart Association

ARTICLES

Rate-related electrophysiologic effects of long-term administration of amiodarone on canine ventricular myocardium in vivo

KP Anderson, R Walker, T Dustman, RL Lux, PR Ershler, RE Kates and PM Urie
Cardiology Division, University of Utah Medical Center, Salt Lake City 84132.

The electrophysiologic effects of amiodarone were examined in 13 dogs that received 30 g amiodarone orally during 3 weeks and compared with 13 control dogs that did not receive amiodarone. Longitudinal and transverse epicardial conduction velocities were estimated with a square array of 64 closely spaced electrodes and a computer-assisted acquisition and analysis system. Amiodarone caused a rate-dependent decrease in conduction velocity with a slightly greater effect in the longitudinal direction of propagation. Rate-related depression of conduction velocity developed rapidly after abrupt shortening of the pacing cycle length; 67% of the change occurred between the first two beats of the rapid train, and little change occurred after the 10th beat. Recovery from use-dependent depression of conduction velocity was exponential with a mean time constant of 447 +/- 172 msec in the longitudinal direction and 452 +/- 265 msec in the transverse direction. Repolarization intervals, defined as the interval between the activation time and the repolarization time in the unipolar electrograms, correlated highly with refractory period determinations in the absence and presence of amiodarone at each cycle length tested. The increase in repolarization intervals and refractory periods resulting from amiodarone treatment did not vary with cycle length. Amiodarone treatment also resulted in a significant rate-related reduction in systolic blood pressure. The systolic blood pressure in the group that received amiodarone decreased by a mean of 50 +/- 23% between steady-state pacing cycle lengths of 1,000 and 200 msec, whereas the corresponding decrease in the control group was 21 +/- 32% (p less than 0.05). Plasma and myocardial amiodarone and desethylamiodarone levels were comparable to those observed clinically. We conclude that long-term amiodarone administration causes rate- dependent reductions in conduction velocity and blood pressure and causes rate-independent increases in repolarization intervals.

This article has been cited by other articles:

				M. J. P. Raatikainen, T. E. Morey, P. Druzgala, P. Milner, M. D. Gonzalez, and D. M. Dennis Potent and Reversible Effects of ATI-2001 on Atrial and Atrioventricular Nodal Electrophysiological Properties in Guinea Pig Isolated Perfused Heart J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 779 - 785. [Abstract] [Full Text]

				W. Sun, J. S. M. Sarma, and B. N. Singh Electrophysiological Effects of Dronedarone (SR33589), a Noniodinated Benzofuran Derivative, in the Rabbit Heart : Comparison With Amiodarone Circulation, November 30, 1999; 100(22): 2276 - 2281. [Abstract] [Full Text] [PDF]

				J. Merot, F. Charpentier, J.-M. Poirier, G. Coutris, and J. Weissenburger Effects of chronic treatment by amiodarone on transmural heterogeneity of canine ventricular repolarization in vivo: interactions with acute sotalol Cardiovasc Res, November 1, 1999; 44(2): 303 - 314. [Abstract] [Full Text] [PDF]

				P. Daleau Effects of Antiarrhythmic Agents on Junctional Resistance of Guinea Pig Ventricular Cell Pairs J. Pharmacol. Exp. Ther., March 1, 1998; 284(3): 1174 - 1179. [Abstract] [Full Text]

				I. Kodama, K. Kamiya, and J. Toyama Cellular electropharmacology of amiodarone Cardiovasc Res, July 1, 1997; 35(1): 13 - 29. [Full Text] [PDF]

				E. P. Anyukhovsky, E. A. Sosunov, and M. R. Rosen Electrophysiologic Effects of Nibentan (HE-11) on Canine Cardiac Tissue J. Pharmacol. Exp. Ther., March 1, 1997; 280(3): 1137 - 1146. [Abstract] [Full Text]

				S. Chun and B. N. Singh Sudden Death During Flecainide Therapy for Atrial Fibrillation Complicating Wolff-Parkinson-White Syndrome Journal of Cardiovascular Pharmacology and Therapeutics, April 1, 1996; 1(2): 159 - 164. [Abstract] [PDF]

				S. Ranger and S. Nattel Determinants and Mechanisms of Flecainide-Induced Promotion of Ventricular Tachycardia in Anesthetized Dogs Circulation, September 1, 1995; 92(5): 1300 - 1311. [Abstract] [Full Text]

				J. N. Nanas and J. W. Mason Pharmacokinetics and Regional Electrophysiological Effects of Intracoronary Amiodarone Administration Circulation, January 15, 1995; 91(2): 451 - 461. [Abstract] [Full Text]